COX-2 Inhibitors, Other NSAIDs, and Cardiovascular Risk

Author:

4 October 2006

journal article
editorial
Published by American Medical Association (AMA) in JAMA

Vol. 296 (13) , 1653-1656
DOI:10.1001/jama.296.13.jed60058
PMID:16968830

Abstract

The concept was appealing in its simplicity. Traditional nonsteroidal anti-inflammatory drugs (NSAIDs) inhibited both isoforms of the enzyme cyclooxygenase resp

Keywords

HEART DISEASE RISK FACTORS
ANTI-INFLAMMATORY AGENTS
NON-STEROIDAL
CYCLOOXYGENASE-2 INHIBITORS
ROFECOXIB
NAPROXEN